Swing Therapeutics, Inc.
PrivateLast Round
Early Funding
Aug 29, 2025
Total Funding Raised
$30.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Swing Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Early Funding round in August 2025.
Swing Therapeutics, Inc. is a digital health company that develops evidence-backed, software-based treatments for chronic conditions like fibromyalgia.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Biotechnology, Telemedicine, Clinical Trials
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swing Therapeutics, Inc. Comparables
Compare Swing Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Override | 82% | |
| Mindset Health | 81% | |
| Lin Health | 78% |
For institutional investors. Book with your work email.
Swing Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 29, 2025 | ||||
| Series A | Jun 16, 2022 | ||||
| Seed | Aug 11, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Swing Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kicker Ventures | Series A |
| Gaingels | Series A |
| JAZZ Venture Partners | Seed, Series A |
| Asahi Kasei Corporate Venture Capital | Series A |
| Metrodora | Series A |
| AME Cloud Ventures | Series A |
| Alumni Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 79% MoM, reaching 12.2K.
- Aug 29, 2025
$11M raised in early funding.
For institutional investors. Book with your work email.
Swing Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Swing Therapeutics, Inc.'s valuation, stock price, and market status.
Is Swing Therapeutics, Inc. a public or private company?
Swing Therapeutics, Inc. is a private company.
What is the current stock price of Swing Therapeutics, Inc.?
Swing Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Swing Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Swing Therapeutics, Inc. worth (valuation)?
Valuation information for Swing Therapeutics, Inc. is not publicly available.
Can I buy Swing Therapeutics, Inc. stock?
Swing Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Swing Therapeutics, Inc.'s last funding round?
Swing Therapeutics, Inc.'s most recent funding round was Early Funding on August 29, 2025.
Who are the main investors in Swing Therapeutics, Inc.?
Key investors in Swing Therapeutics, Inc. include JAZZ Venture Partners.
Will Swing Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Swing Therapeutics, Inc..
How can I track Swing Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Swing Therapeutics, Inc.'s shares on secondary markets.